Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Clinical Mass Spectrometry Market – Insights

Clinical mass spectrometry is widely accepted in research, specialized clinical laboratories, and its adoption is significantly increasing in routine laboratories. The combination of mass spectrometry with gas chromatography (GC) or liquid chromatography (LC) has contributed to the rapid expansion of this technology. Mass spectrometry (MS) has application in many clinical areas such as therapeutic drug monitoring, drugs of abuse, and clinical toxicology.

Clinical mass spectrometry serves as a quantitative and qualitative analytical tool for assessment of complex mixtures in all phases of drug development such as identification of the lead compound and their conformational details. Clinical laboratories manage a large number of samples through total automation or analyzer automation, which is offered by clinical mass spectrometers such as matrix assisted laser desorption/ionization (MALDI-TOF). These automated platforms assist in effective processing of increasingly large workloads. Thus, clinical laboratories are among the largest end users in this market.

Moreover, advancements in clinical mass spectrometry has facilitated measuring and distinguishing of separate contributions of molecules such as thyroid hormones and 25-hydroxyl vitamins D2 and D3. Application of translational research in mass spectrometry has helped in detecting blood-based biomarkers, endogenous metabolites, tumor markers, and new disease biomarkers. These advancements are expected to fuel demand for clinical mass spectrometry devices.

The global clinical mass spectrometry market size is estimated to be valued at US$ 697.2 million in 2019, and is expected to exhibit a CAGR of 5.5% over the forecast period (2019 – 2027).

Global Clinical Mass Spectrometry Market Share (%) Analysis, By Product Type, 2019

Clinical Mass Spectrometry  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing demand for automation in diagnostic techniques is expected to drive growth of the clinical mass spectrometry market

Mass spectrometry helps with a variety of diagnostic analysis, and research in functional genomics, metabolomics, and proteomics. These factors are driving the need for development of a cost-effective platform for sample analysis. As a result, manufacturers are focused on product development and innovations to address the demand for automated diagnostic tools. For instance, in 2017, Thermo Fisher Scientific Inc. launched Scientific Cascadion SM Clinical Analyzer at a EuroMedLab event held in Athens, Greece, to use the clinical analyzers with the selectivity and sensitivity of liquid chromatography-tandem mass spectrometry.

Automated laboratory systems provide several high-end functionalities such as MassEXTEND primer extension and nano liter dispensing of samples on to spectroCHIPS, and data analysis by using pre-loaded workstations. Ease of management, quick results, and less complex functionality by these facilities is associated with low cost. Apart from cost-effectiveness, improved quality assays, simplicity for use, automation, data reliability, increased sensitivity, reduced cross-reactivity & non-specific binding, and low downtime are the advantages offered by mass spectrometers over conventional immunoassays.

Clinical Mass Spectrometry Market – Restraints

The capital investment associated with installation and maintenance of these devices is expected to restrain growth of the global market. Mass spectrometers are largely unaffordable for small diagnostic clinics and laboratories especially in emerging economies. Moreover, mass spectrometry is labor intensive and requires skilled workforce to operate the devices. Shortage of skilled operators is expected to hamper the market growth.

Clinical Mass Spectrometry Market - Regional Insights

On the basis of region, the global clinical mass spectrometry market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold the largest share in the clinical mass spectrometry market over the forecast period, owing to Research and development activities, coupled with governmental support are factors driving growth of the North America market. For instance, the Federation of analytical Chemistry and Spectrometry Societies, and American Society for Mass Spectrometry, which was formed in 1969, with over 7,500 scientists working together on advancing clinical application of mass spectrometry and allied topics in academic, industrial, and governmental fields. This has created a strong research base in North America which is  contributing to the growth of the clinical mass spectrometry market in the region.

Global Clinical Mass Spectrometry Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027

Clinical Mass Spectrometry  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Clinical Mass Spectrometry Market - Competitive Landscape

Major players operating in the global clinical mass spectrometry market include Bruker Corporation, Kore Technology Limited, Bergman Messgerate Entwicklung KG, Mass Spectrometry Instruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies, and Danaher Corporations.

Clinical mass spectrometry plays a vital role in the drug discovery pipeline for development of personalized medicines. It is further used in live imaging of biological tissue samples for detection of biomarkers. Cost reduction and improved assay quality are the key factors driving the adoption of mass spectrometry technique. According to the American Association for Clinical Chemistry (AACC), the greater specificity of liquid chromatography–mass spectrometry (LC-MS) enables the measuring of testosterone in the patients with low endogenous concentrations. This technique is more reliable than traditional immunoassays, especially in women and children. This has led to an early adoption of the most recent generation of instruments using an established technology in the laboratories. 

Clinical diagnostic mass spectrometers have the potential to analyze limited range of samples such as biomarkers, proteins or drug molecules at once, and in

Some cases with low concentrations. Thus, these devices are a valuable tool in diagnostics and laboratory settings. Furthermore, it allows researchers to determine pharmacokinetic profiles of drugs that are administered in micro doses. The technology shift from traditional systems to high-resolution technologies such as Quadrupole-time of flight (Q-TOF) mass spectrometry and the demand for this spectrometry technique type is expected to grow rapidly owing to advantages such as accuracy, improved resolution, and sensitivity for clinical diagnostic applications.

Market Dynamics

Technological advancements and product launches by key players are expected to drive growth of the clinical mass spectrometry market. Advancements in technology include miniaturization of mass spectrometry instruments and increasing automation within spectrometric units to reduce human efforts and improve efficiency of the instrument. For instance, a fully automated analyzer launched by Thermo Fisher, in June 2017 that can be customized for compatibility with laboratory information systems.

Key features of the study:

  • This report provides in-depth analysis of the global clinical mass spectrometry market size (US$ Mn), and compound annual growth rate (CAGR (%)) over the forecast period: 2019 – 2027, considering 2018 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global clinical mass spectrometry market based on the following parameters – company overview, financial performance, product portfolio, geographical presence,  key developments, and strategies
  • Key players covered as a part of this study include Bruker Corporation Kore Technology Limited, Bergman Messgerate Entwicklung KG, Mass Spectrometry Instruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies, and Danaher Corporations
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, market expansion, and marketing tactics
  • The global clinical mass spectrometry report caters to various stakeholders in this industry which include investors, product manufacturers, distributors, and suppliers of clinical mass spectrometry, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Clinical Mass Spectrometry Market, By Product Type:
    • Gas chromatography-mass spectrometry (GC-MS) instrument
    • Liquid chromatography-mass spectrometry (LC-MS) instrument
    • Maldi TOF mass spectrometer
    • Capillary electrophoresis-mass spectrometry
    • Ion mobility spectrometry-mass spectrometry
  • Global Clinical Mass Spectrometry Market, By Application:
    • Clinical Testing
    • Proteomics
    • Drug discovery
  • Global Clinical Mass Spectrometry Market, By End User:
    • Research Laboratories
    • Diagnostic Laboratories
    • Hospitals
  • Global Clinical Mass Spectrometry Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type
        • Gas chromatography–mass spectrometry (GC-MS) instrument
        • Liquid chromatography–mass spectrometry (LC-MS) instrument
        • Maldi TOF mass spectrometer
        • Capillary electrophoresis-mass spectrometry
        • Ion mobility spectrometry-mass spectrometry
      • By Application
        • Clinical Testing
        • Proteomics
        • Drug discovery
      • By End User
        • Research Laboratories
        • Diagnostic Laboratories
        • Hospitals
    •  Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type
        • Gas chromatography–mass spectrometry (GC-MS) instrument
        • Liquid chromatography–mass spectrometry (LC-MS) instrument
        • Maldi TOF mass spectrometer
        • Capillary electrophoresis-mass spectrometry
        • Ion mobility spectrometry-mass spectrometry
      • By Application
        • Clinical Testing
        • Proteomics
        • Drug discovery
      • By End User
        • Research Laboratories
        • Diagnostic Laboratories
        • Hospitals
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type
        • Gas chromatography–mass spectrometry (GC-MS) instrument
        • Liquid chromatography–mass spectrometry (LC-MS) instrument
        • Maldi TOF mass spectrometer
        • Capillary electrophoresis-mass spectrometry
        • Ion mobility spectrometry-mass spectrometry
      • By Application
        • Clinical Testing
        • Proteomics
        • Drug discovery
      • By End User
        • Research Laboratories
        • Diagnostic Laboratories
        • Hospitals
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product Type
        • Gas chromatography–mass spectrometry (GC-MS) instrument
        • Liquid chromatography–mass spectrometry (LC-MS) instrument
        • Maldi TOF mass spectrometer
        • Capillary electrophoresis-mass spectrometry
        • Ion mobility spectrometry-mass spectrometry
      • By Application
        • Clinical Testing
        • Proteomics
        • Drug discovery
      • By End User
        • Research Laboratories
        • Diagnostic Laboratories
        • Hospitals
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type
        • Gas chromatography–mass spectrometry (GC-MS) instrument
        • Liquid chromatography–mass spectrometry (LC-MS) instrument
        • Maldi TOF mass spectrometer
        • Capillary electrophoresis-mass spectrometry
        • Ion mobility spectrometry-mass spectrometry
      • By Application
        • Clinical Testing
        • Proteomics
        • Drug discovery
      • By End User
        • Research Laboratories
        • Diagnostic Laboratories
        • Hospitals
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type
        • Gas chromatography–mass spectrometry (GC-MS) instrument
        • Liquid chromatography–mass spectrometry (LC-MS) instrument
        • Maldi TOF mass spectrometer
        • Capillary electrophoresis-mass spectrometry
        • Ion mobility spectrometry-mass spectrometry
      • By Application
        • Clinical Testing
        • Proteomics
        • Drug discovery
      • By End User
        • Research Laboratories
        • Diagnostic Laboratories
        • Hospitals
  • Company Profiles
    • Bruker Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Kore Technologies
    • Bergman Messgerate Entwicklung KG
    • Mass Spectrometry Instruments (MSI)
    • RGB Photonics
    • ABLE Biosciences
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies
    • PerkinElmer Inc.
    • Shimadzu Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Landscape
    • Porter’s Five Forces Model
  4. Global Clinical Mass Spectrometry Market, By Product Type, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Gas chromatography-mass spectrometry (GC-MS) instrument
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Liquid chromatography–mass spectrometry (LC-MS) instrument 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Maldi TOF mass spectrometer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Capillary electrophoresis–mass spectrometry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Ion mobility spectrometry-mass spectrometry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
  5. Global Clinical Mass Spectrometry Market, By Application, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Clinical Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Proteomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Drug Discovery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
  6. Global Clinical Mass Spectrometry Market, By End User, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Research Laboratories
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Diagnostic Laboratories
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
  7. Global Clinical Mass Spectrometry Market, By Region, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, By Region, 2018– 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By  Product Type, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By  Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By  Product Type, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By  Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By  Product Type, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By  Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By  Product Type, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By  Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By  Product Type, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By  Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By  Product Type, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By  Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Company Profiles
      • Bruker Corporations
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Kore Technologies
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Bergman Messgerate Entwicklung KG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Mass Spectrometry Instruments (MSI)
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • RGB Photonics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • ABLE Biosciences
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Danaher Corporations
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Agilent Technologies
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Shimadzu Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • PerkinElmer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 43 market data tables and 33 figures on “Clinical Mass Spectrometry Market” - Global forecast to 2027”

Frequently Asked Questions

The global clinical mass spectrometry market is estimated to surpass US$ 1,206.9 Million by 2027.
Major players operating in the global clinical mass spectrometry market include Bruker Corporation, Kore Technology Limited, Bergman Messgerate Entwicklung KG, Mass Spectrometry Instruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies, and Danaher Corporations.
Shortage of skilled operators is one of the major factors that is expected to hamper growth of the market over the forecast period.
Increasing demand for automation in diagnostic techniques is one of the major factors that is expected to propel growth of the market over the forecast period.
The global clinical mass spectrometry market is estimated to exhibit a CAGR of 5.5% over the forecast period.
Among regions, North America is expected to hold dominant position in the clinical mass spectrometry market over the forecast period.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner